On May 20, 2025, ASP Isotopes Inc. announced an agreement to acquire Renergen Limited by offering shares of its common stock for Renergen's ordinary shares, potentially making Renergen a wholly owned subsidiary. The deal may affect the ownership structure, with Renergen shareholders expected to hold approximately 16% of ASP's shares post-transaction.